Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 239.67 USD -0.21% Market Closed
Market Cap: 20B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Operating Margin
Laboratory Corporation of America Holdings

8.9%
Current
15%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
8.9%
=
Operating Profit
1.1B
/
Revenue
12.7B

Operating Margin Across Competitors

Country US
Market Cap 20.1B USD
Operating Margin
9%
Country US
Market Cap 91.8B USD
Operating Margin
4%
Country US
Market Cap 87.7B EUR
Operating Margin
4%
Country US
Market Cap 73B USD
Operating Margin
3%
Country DE
Market Cap 24.9B EUR
Operating Margin
7%
Country DE
Market Cap 18.8B EUR
Operating Margin
7%
Country US
Market Cap 18.3B USD
Operating Margin
14%
Country US
Market Cap 13.7B USD
Operating Margin
15%
Country DE
Market Cap 12.4B EUR
Operating Margin
7%
Country AU
Market Cap 13.4B AUD
Operating Margin
9%
Country US
Market Cap 8.6B USD
Operating Margin
17%
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Market Cap
20.1B USD
Industry
Health Care

Laboratory Corporation of America Holdings, commonly referred to as LabCorp, has established itself as a leader in the biomedical testing and diagnostics industry. Founded in 1971, the company operates with a mission to improve health and improve lives by providing critical laboratory services to healthcare providers, pharmaceutical companies, and patients. LabCorp offers a comprehensive range of tests, encompassing everything from routine blood work to complex genomic testing. This diverse portfolio positions LabCorp to benefit from the growing demand for diagnostic services, particularly as healthcare continues to evolve toward precision medicine and personalized care. For investors, LabCorp's strategic initiatives and strong financial performance paint a compelling picture. The company has successfully expanded through a series of acquisitions, enhancing its capabilities and market reach. With a focus on innovation, LabCorp has invested heavily in advanced technologies and digital solutions to streamline operations and enhance customer experience. As the healthcare landscape shifts toward value-based care, LabCorp is well-positioned to capture market share and drive revenue growth. With a history of consistent earnings and a commitment to shareholder value, LabCorp represents a potentially attractive investment for those looking to engage in the evolving healthcare sector.

LH Intrinsic Value
259.89 USD
Undervaluation 8%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
8.9%
=
Operating Profit
1.1B
/
Revenue
12.7B
What is the Operating Margin of Laboratory Corporation of America Holdings?

Based on Laboratory Corporation of America Holdings's most recent financial statements, the company has Operating Margin of 8.9%.